Dr. Francis has been a practicing Obstetrician/Gynecologist since 2003, after graduating with her MD from UCONN School of Medicine and completing her residency at NYU Downtown. While serving on EverlyWell's leadership team as a full-time Medical Director, responsible for clinical research and our go-to-market test strategy, she maintains a sub-specialty Gynecological practice to identify women at risk for Hereditary Cancer Syndromes. Dr. Francis served as a National Speaker and Key Opinion Leader for Myriad Genetics, Inc. for 10 years, and has served similar roles for other companies. She is the former Chief Medical Officer for Vermillion, Inc.
Walter is a laboratory management and operations professional with experience in a number of laboratory specialties including molecular diagnostics, infectious disease, immunology, chemistry, toxicology, histology and hematology. He graduated from Auburn University with a degree in Cellular, Molecular and Microbiology and is an ASCP board-certified Molecular Biologist. Walter has started, operationalized and obtained certification and accreditation for a number of reference and hospital-based laboratories throughout his career. He serves on EverlyWell's leadership team as the Director of Laboratory Operations and manages laboratory partnerships and ensures testing quality and compliance.
Todd is a clinical diagnostic development specialist with over 25 years of experience in Research & Development and leads EverlyWell's Clinical Research team. Todd has helped companies develop innovative multivariate and multi-analyte tests for cancer and infectious diseases, including the development and validation of an FDA-cleared multivariate index assay for ovarian cancer. He has helped develop algorithm-based diagnostics, as well as syndromic and emerging infectious disease products with medical device manufacturers and the US Department of Defense. Additionally, Todd has extensive experience conducting retrospective and prospective clinical studies addressing assay validation, clinical utility and physician utilization of diagnostic tests. He conducted basic research in biomedical engineering, neurovirology and neuroendocrinology, and holds a PhD in Neuroscience and an MS and BS in Biology.